Epidemic keratoconjuctivitis.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E J Bell.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Studies were made on the isolation and identification of the Rickettsia typhi toxin-neutralizing factor (TNF) previously demonstrated in normal human serum. By means of various methods of separating serum proteins, such as filtration on Sephadex G-200, dextran precipitation, hydroxyapatite chromatography, and ultracentrifugation, TNF was found to be closely associated with purified serum beta-lipoprotein, although no serological relationship with this protein was demonstrated. Lipase as well as trypsin digestion of purified preparations of beta-lipoprotein destroyed the TN activity. No evidence was obtained for an association of TNF with the immunoglobulins or with any serum protein other than beta-lipoprotein. Further studies revealed that (i) serum specimens with TN titers of 1:1024 and others with titers of 1:8 or less contained the same concentration of beta-lipoprotein; (ii) purified preparations of beta-lipoprotein isolated from TNF positive and negative sera, and which had the same protein concentration, differed as much as 250-fold in TN titer; and (iii) the TN activity of a serum could be removed by absorption with antiserum to beta-lipoprotein from a positive donor, but not with antiserum to beta-lipoprotein from a negative donor.
Explore the source record for details and available documents.
A modified micrometabolic inhibition test for the titration of poliovirus neutralizing antibodies is described. The effects of varying both the duration and the temperature of incubation of the serum-virus mixtures were examined. Overnight incubation resulted in a 2-3-fold increase in the titre of the hyperimmune sera tested. The method is simple and economical and appears to be suitable for antibody surveys.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.